Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge
On Jun. 24, 2015, Oregon Health & Science University announced it had met Nike co-founder Phil Knight and…
-
-
Rutgers Cancer Institute of New Jersey was one of seven worldwide sites to offer debulking prostatectomy
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
-
Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the State of Florida
On Mar. 25, 2015, the Sylvester Comprehensive Cancer Center was designated a Cancer Center of Excellence by the…
-
Dendreon was acquired by Valeant Pharmaceuticals for $495 million
On Feb. 23, 2015, a bankruptcy judge approved the sale of the assets of Dendreon Corp., a Seattle-based…
-
Yale Cancer Center was awarded a SPORE grant for translational research in lung cancer
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
-
The Fred & Pamela Buffett Cancer Center announced recruitment of five leading cancer researchers
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
-
Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
-
Researchers unlock genetic code of cancer-causing liver fluke parasite
On Sept. 10, 2014, an international team of scientists from Singapore, Thailand, China and Australia announced that they…
-
Mary-Claire King received Lasker Foundation Award
On Sept. 8, 2014, the University of Washington and UW Medicine announced that Mary-Claire King, UW professor of…
-
University of Missouri School of Medicine received $2.4 million gift to funds endowed faculty chair in oncology
On Aug. 21, 2014, Mark McAndrew, a resident of McKinney, Texas, gave $2.4 million to the University of…
-
Biotechnology | Chemistry | FDA | Oncology | Therapeutics | Women's Health
FDA approved Genentech’s Avastin plus chemotherapy for treatment of advanced cervical cancer
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
-
OHSU Knight Cancer Challenge announced $100 million gift
On Jul. 28, 2014, Oregon Health & Science University’s (OHSU) Knight Cancer Institute announced it has received a…
-
Case Western Reserve University announced major philanthropic pledges
On Jun. 30, 2014, leaders from Case Western Reserve University and University Hospitals announced that Char and Chuck…
-
The Burnham Institute for Medical Research announced record $275 million gift
On Jun. 28, 2014, The Sanford-Burnham Medical Research Institute has received the largest-ever single donation to a local…
-
OHSU Collaborative Life Sciences Building launched new era in health and science research and education
On Jun. 26, 2014, a $300 million building opened in Portland is shared by Portland State University and Oregon…
-
Bezos family donated $20 million to the Fred Hutch to develop therapies that ‘melt’ cancer
On Apr. 7, 2014, the Fred Hutchinson Cancer Research Center announced that the Bezos family had committed $20…
-
Laura and Isaac Perlmutter donated $50 million to advance cancer research and treatment at NYU Langone Medical Center
On Jan. 29, 2014, NYU Langone Medical Center announced it had received an initial gift in excess of…
-
Siteman Cancer Center debuted the first single-vault proton therapy center in the country
On Dec. 19, 2013, the Siteman Cancer Center debuted the first single-vault proton therapy center in the U.S.:…
-
Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
-
Karmanos Cancer Institute joined McLaren Health Care
On Oct. 30, 2013, The Barbara Ann Karmanos Cancer Institute and McLaren Health Care signed an agreement today…
-
OHSU launched a $25 million clinical and translational science initiative against lethal, hard-to-treat pancreatic disease
On Sept. 12, 2013, Oregon Health & Science University (OHSU) announced it had launched a clinical and translational…
-
The Markey Cancer Center became an NCI-designated Cancer Center
On Jul. 12, 2013. the University of Kentucky Markey Cancer Center (MCC) was joined by national, state and…
-
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
UNMC Renamed Eppley Cancer Center to the Fred & Pamela Buffett Cancer Center
In Jun. 7, 2013, the University of Nebraska Board of Regents approved changing the name of the UNMC…
-
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had licensed ado-trastuzumab emtansine (Kadcyla)…
-
The Connecticut Challenge Survivorship Clinic Opened at Yale Cancer Center
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
-
The University of Kansas Cancer Center earned National Cancer Institute designation
On Jul. 12, 2012, a decade after declaring its goal of becoming a National Cancer Institute-designated facility, the…
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology | Therapeutics
The University of Hawaii Cancer Center received NCI designation renewal
On Jun. 29, 2012, following a competitive renewal process, the National Cancer Institute announced it had awarded the…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
-
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
